<DOC>
	<DOCNO>NCT02870907</DOCNO>
	<brief_summary>Postoperative Treatment Unilateral Retinoblastoma After Primary Enucleation accord histopathological risk factor International Retinoblastoma Staging Working Group .</brief_summary>
	<brief_title>Adjuvant Treatment Extensive Unilateral Retinoblastoma Primary Enucleated ( RB SFCE 2009 )</brief_title>
	<detailed_description>Post operative chemotherapy +/- radiotherapy accord histopathological risk factor International Retinoblastoma Staging Working Group . - Low risk group : - No optic nerve involvement . - Intra prelaminar involvement - No choroidal involvement . - Minimal superficial choroidal involvement . - Intermediate risk group , 2 sub group : - Sub group 1 : - Retrolaminar involvement without Invasion surgical margin associate massive choroidal involvement - Anterior segment involvement . - Intrascleral involvement . - Sub Group 2 : - Isolated massive choroidal involvement . - High risk group : - Invasion surgical margin optic nerve - and/or microscopic extrascleral involvement - Optic nerve meningeal sheat involvement .</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>1 . Written inform consent sign informed consent and/or assent ( age appropriate ) obtain accord institutional guideline ; 2 . Male female ≥2 month &lt; 10 year age time sign informed consent form ; 3 . Diagnosis non familial extensive unilateral retinoblastoma treat primary enucleation 4 . In case post operative chemotherapy , patient must adequate organ function : Adequate hematopoietic function Neutrophils &gt; 1.0x109/l , Platelets &gt; 100 x 109/l . Adequate hepatic function : grade II NCI CTC Adequate renal function : serum creatinemia &lt; 1.5 x ULN age normal creatinine clearance estimate SCHWARTZ formula Audiometry &lt; Grade II de Brock . Echocardiography normal case high dose cyclophosphamide chemotherapy ( 3 g/m² ) . 5 . Patients affiliate Social Security Regimen beneficiary 6 . No chemotherapy radiotherapy prior administration first dose study treatment retinoblastoma tumor type 7 . Without medical consindication study drug . Bilateral and/or familial trilateral retinoblastoma . Unilateral retinoblastoma indication primary chemotherapy enucleation : One several surgical risk factor Buphthalmia Exophthalmia . Peri ocular inflammatory sign . Extraocular extension : Radiological retrolaminar extension ( 3 mm behind lamina cribrosa ) meningeal sheat optic nerve extension . Extrascleral extension Lymp nod extension Unilateral retinoblastoma possibility conservative treatment : Metastatic extension diagnosis One inclusion criterion non observe Uncontrolled medical condition , psychological , familial , sociological , geographical condition permit compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>primary enucleation</keyword>
	<keyword>retinoblastoma</keyword>
</DOC>